Results 211 to 220 of about 120,317 (381)

HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children

open access: green, 2013
Ursula Amstutz   +6 more
openalex   +2 more sources

Association between SCN1A polymorphism and carbamazepine‐resistant epilepsy [PDF]

open access: bronze, 2008
Tomohide Abe   +5 more
openalex   +1 more source

Drug discovery and preclinical testing of drug candidates for developmental and epileptic encephalopathies

open access: yesEpilepsia, EarlyView.
Abstract Drug development for developmental and epileptic encephalopathies (DEEs) follows different strategies on one hand including disease‐targeting precision medicine approaches considering the genetic variants and pathomechanisms in DEEs and on the other hand including therapeutic approaches with novel targets or second‐generation drug candidates ...
Heidrun Potschka, Daniel Pérez‐Pérez
wiley   +1 more source

Climate change and hyponatremia‐related hospital admissions in people with focal epilepsy exposed to carbamazepine or its derivatives

open access: yesEpilepsia, EarlyView.
Abstract Objective To estimate the proportion of individuals with focal epilepsy treated with at least one among carbamazepine (CBZ), oxcarbazepine (OXC), or eslicarbazepine (ESL), who were hospitalized due to hyponatremia‐related symptoms in 2024, and to test the hypothesis that there is an association with climatic variables.
Francesco Fortunato   +17 more
wiley   +1 more source

Maternal Exposure to Carbamazepine at Environmentally Relevant Concentrations Causes Growth Delay in Mouse Embryos. [PDF]

open access: yesACS Omega
Veretnik E   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy